Aytu Biopharma (AYTU) Amortization of Deferred Charges (2016 - 2026)
Aytu Biopharma (AYTU) reported Amortization of Deferred Charges of $27000.0 for Q1 2026, little changed year-over-year from $27000.0 in Q1 2025, and down 6.9% quarter-over-quarter from $29000.0 in Q4 2025.
Aytu Biopharma (AYTU) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 8 years of Amortization of Deferred Charges data on file, last reported at $27000.0 in Q1 2026.
- Amortization of Deferred Charges for Q1 2026 came in at $27000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $111000.0 (down 48.61% YoY), and the FY2025 annual result was $108000.0, down 81.91% from the prior year.
- Amortization of Deferred Charges slipped to $27000.0 in Q1 2026 per AYTU's latest filing, from $29000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $170000.0 in Q4 2022 and troughed at $26000.0 in Q2 2025.
- A 5-year average of $93588.2 and a median of $100000.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2022 and 2025: Amortization of Deferred Charges jumped 203.03% in 2022, then plunged 83.23% in 2025.
- A 5-year view of Amortization of Deferred Charges shows it stood at $170000.0 in 2022, then slipped by 9.41% to $154000.0 in 2023, then sank by 81.82% to $28000.0 in 2024, then climbed by 3.57% to $29000.0 in 2025, then dropped by 6.9% to $27000.0 in 2026.
- Business Quant data shows AYTU's Amortization of Deferred Charges at $27000.0 in Q1 2026, $29000.0 in Q4 2025, and $29000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 27,000.00 |
| Sep 30, 2024 | 27,000.00 |
| Jun 30, 2024 | 134,000.00 |
| Jun 30, 2024 | 134,000.00 |
| Mar 31, 2024 | 161,000.00 |
| Mar 31, 2024 | 161,000.00 |
| Dec 31, 2023 | 154,000.00 |
| Dec 31, 2023 | 154,000.00 |